annual operating expenses:
$8.14B+$1.07B(+15.16%)Summary
- As of today (June 29, 2025), REGN annual total operating expenses is $8.14 billion, with the most recent change of +$1.07 billion (+15.16%) on December 31, 2024.
- During the last 3 years, REGN annual operating expenses has risen by +$3.50 billion (+75.45%).
- REGN annual operating expenses is now at all-time high.
Performance
REGN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.97B-$260.90M(-11.68%)Summary
- As of today (June 29, 2025), REGN quarterly total operating expenses is $1.97 billion, with the most recent change of -$260.90 million (-11.68%) on March 31, 2025.
- Over the past year, REGN quarterly operating expenses has increased by +$12.90 million (+0.66%).
- REGN quarterly operating expenses is now -11.68% below its all-time high of $2.23 billion, reached on December 31, 2024.
Performance
REGN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
REGN Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.2% | +0.7% |
| 3 y3 years | +75.5% | +51.5% |
| 5 y5 years | +127.2% | +116.6% |
REGN Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.5% | -11.7% | +51.5% |
| 5 y | 5-year | at high | +127.2% | -11.7% | +118.5% |
| alltime | all time | at high | >+9999.0% | -11.7% | +532.6% |
REGN Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.97B(-11.7%) |
| Dec 2024 | $8.14B(+15.2%) | $2.23B(+9.0%) |
| Sep 2024 | - | $2.05B(+2.6%) |
| Jun 2024 | - | $2.00B(+1.9%) |
| Mar 2024 | - | $1.96B(+0.8%) |
| Dec 2023 | $7.07B(+25.8%) | $1.94B(+7.1%) |
| Sep 2023 | - | $1.82B(+4.5%) |
| Jun 2023 | - | $1.74B(-1.2%) |
| Mar 2023 | - | $1.76B(+1.8%) |
| Dec 2022 | $5.62B(+21.1%) | $1.73B(+23.8%) |
| Sep 2022 | - | $1.39B(-3.8%) |
| Jun 2022 | - | $1.45B(+11.4%) |
| Mar 2022 | - | $1.30B(-2.1%) |
| Dec 2021 | $4.64B(+22.1%) | $1.33B(+15.4%) |
| Sep 2021 | - | $1.15B(+5.0%) |
| Jun 2021 | - | $1.10B(-0.9%) |
| Mar 2021 | - | $1.11B(+22.7%) |
| Dec 2020 | $3.80B(+6.1%) | $902.80M(-6.6%) |
| Sep 2020 | - | $966.90M(-5.2%) |
| Jun 2020 | - | $1.02B(+12.0%) |
| Mar 2020 | - | $910.80M(-5.7%) |
| Dec 2019 | $3.58B(+63.3%) | $966.10M(+23.9%) |
| Sep 2019 | - | $779.70M(-30.2%) |
| Jun 2019 | - | $1.12B(+54.9%) |
| Mar 2019 | - | $720.50M(-258.0%) |
| Dec 2018 | $2.19B(-35.4%) | -$456.00M(-149.2%) |
| Sep 2018 | - | $926.20M(+3.6%) |
| Jun 2018 | - | $894.10M(+7.8%) |
| Mar 2018 | - | $829.40M(-11.6%) |
| Dec 2017 | $3.40B(+5.1%) | $937.82M(+12.1%) |
| Sep 2017 | - | $836.51M(+2.4%) |
| Jun 2017 | - | $816.88M(+1.6%) |
| Mar 2017 | - | $804.28M(-0.1%) |
| Dec 2016 | $3.23B(+31.3%) | $805.15M(-1.0%) |
| Sep 2016 | - | $813.09M(-4.6%) |
| Jun 2016 | - | $851.97M(+12.1%) |
| Mar 2016 | - | $759.79M(+0.5%) |
| Dec 2015 | $2.46B(+37.3%) | $756.16M(+18.9%) |
| Sep 2015 | - | $635.92M(+12.6%) |
| Jun 2015 | - | $564.92M(+12.5%) |
| Mar 2015 | - | $502.10M(-4.7%) |
| Dec 2014 | $1.79B(+48.4%) | $527.05M(+9.4%) |
| Sep 2014 | - | $481.73M(+23.1%) |
| Jun 2014 | - | $391.23M(+0.2%) |
| Mar 2014 | - | $390.61M(+6.4%) |
| Dec 2013 | $1.21B(+44.2%) | $367.20M(+14.2%) |
| Sep 2013 | - | $321.65M(+23.7%) |
| Jun 2013 | - | $259.93M(+0.9%) |
| Mar 2013 | - | $257.56M(+7.9%) |
| Dec 2012 | $836.31M(+29.3%) | $238.76M(+16.4%) |
| Sep 2012 | - | $205.18M(+5.2%) |
| Jun 2012 | - | $195.08M(-1.1%) |
| Mar 2012 | - | $197.29M(+19.3%) |
| Dec 2011 | $646.77M(+16.6%) | $165.39M(+2.8%) |
| Sep 2011 | - | $160.84M(-4.1%) |
| Jun 2011 | - | $167.73M(+9.8%) |
| Mar 2011 | - | $152.80M(+4.8%) |
| Dec 2010 | $554.45M(+22.8%) | $145.85M(+5.9%) |
| Sep 2010 | - | $137.70M(-1.1%) |
| Jun 2010 | - | $139.21M(+5.7%) |
| Mar 2010 | - | $131.69M(-3.0%) |
| Dec 2009 | $451.69M(+39.5%) | $135.82M(+14.8%) |
| Sep 2009 | - | $118.27M(+11.7%) |
| Jun 2009 | - | $105.86M(+15.4%) |
| Mar 2009 | - | $91.73M(+6.4%) |
| Dec 2008 | $323.78M | $86.22M(+1.2%) |
| Sep 2008 | - | $85.22M(+6.2%) |
| Jun 2008 | - | $80.27M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $72.29M(-5.2%) |
| Dec 2007 | $239.48M(+47.0%) | $76.26M(+25.1%) |
| Sep 2007 | - | $60.98M(+15.5%) |
| Jun 2007 | - | $52.80M(+6.8%) |
| Mar 2007 | - | $49.44M(+13.9%) |
| Dec 2006 | $162.96M(-340.4%) | $43.40M(+6.3%) |
| Sep 2006 | - | $40.83M(+0.3%) |
| Jun 2006 | - | $40.70M(+7.0%) |
| Mar 2006 | - | $38.03M(-118.6%) |
| Dec 2005 | -$67.78M(-144.3%) | -$204.04M(-531.0%) |
| Sep 2005 | - | $47.34M(+1.0%) |
| Jun 2005 | - | $46.86M(+11.4%) |
| Mar 2005 | - | $42.06M(+6.1%) |
| Dec 2004 | $153.16M(+1.6%) | $39.64M(+7.1%) |
| Sep 2004 | - | $37.01M(-8.7%) |
| Jun 2004 | - | $40.53M(+12.7%) |
| Mar 2004 | - | $35.97M(-4.1%) |
| Dec 2003 | $150.81M(+9.7%) | $37.50M(-2.0%) |
| Sep 2003 | - | $38.25M(+2.8%) |
| Jun 2003 | - | $37.20M(-1.7%) |
| Mar 2003 | - | $37.85M(+0.1%) |
| Dec 2002 | $137.46M(+35.9%) | $37.82M(+1.9%) |
| Sep 2002 | - | $37.11M(+10.2%) |
| Jun 2002 | - | $33.66M(+16.6%) |
| Mar 2002 | - | $28.88M(-12.1%) |
| Dec 2001 | $101.15M(+46.6%) | $32.83M(+19.4%) |
| Sep 2001 | - | $27.50M(+25.1%) |
| Jun 2001 | - | $21.98M(+16.7%) |
| Mar 2001 | - | $18.84M(-6.7%) |
| Dec 2000 | $68.99M(+26.1%) | $20.19M(-27.8%) |
| Sep 2000 | - | $27.97M(+63.0%) |
| Jun 2000 | - | $17.17M(+7.8%) |
| Mar 2000 | - | $15.93M(+27.4%) |
| Dec 1999 | $54.70M(+19.4%) | $12.50M(-18.8%) |
| Sep 1999 | - | $15.40M(+17.6%) |
| Jun 1999 | - | $13.10M(-9.7%) |
| Mar 1999 | - | $14.50M(+20.8%) |
| Dec 1998 | $45.80M(+20.5%) | $12.00M(+0.8%) |
| Sep 1998 | - | $11.90M(+2.6%) |
| Jun 1998 | - | $11.60M(+10.5%) |
| Mar 1998 | - | $10.50M(+12.9%) |
| Dec 1997 | $38.00M(-5.7%) | $9.30M(+1.1%) |
| Sep 1997 | - | $9.20M(-6.1%) |
| Jun 1997 | - | $9.80M(0.0%) |
| Mar 1997 | - | $9.80M(-1.0%) |
| Dec 1996 | $40.30M(+15.1%) | $9.90M(-6.6%) |
| Sep 1996 | - | $10.60M(+7.1%) |
| Jun 1996 | - | $9.90M(0.0%) |
| Mar 1996 | - | $9.90M(+16.5%) |
| Dec 1995 | $35.00M(-33.2%) | $8.50M(-1.2%) |
| Sep 1995 | - | $8.60M(-3.4%) |
| Jun 1995 | - | $8.90M(-1.1%) |
| Mar 1995 | - | $9.00M(-29.7%) |
| Dec 1994 | $52.40M(+6.1%) | $12.80M(+1.6%) |
| Sep 1994 | - | $12.60M(-7.4%) |
| Jun 1994 | - | $13.60M(+1.5%) |
| Mar 1994 | - | $13.40M(-68.5%) |
| Dec 1993 | $49.40M(+65.8%) | $42.60M(+1752.2%) |
| Sep 1993 | - | $2.30M(-79.3%) |
| Jun 1993 | - | $11.10M(-1.8%) |
| Mar 1993 | - | $11.30M(+34.5%) |
| Dec 1992 | $29.80M(+626.8%) | $8.40M(+5.0%) |
| Sep 1992 | - | $8.00M(+19.4%) |
| Jun 1992 | - | $6.70M(0.0%) |
| Mar 1992 | - | $6.70M(+857.1%) |
| Dec 1991 | $4.10M(+105.0%) | $700.00K(-65.0%) |
| Sep 1991 | - | $2.00M(+150.0%) |
| Jun 1991 | - | $800.00K |
| Dec 1990 | $2.00M | - |
FAQ
- What is Regeneron Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual operating expenses year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly operating expenses year-on-year change?
What is Regeneron Pharmaceuticals annual total operating expenses?
The current annual operating expenses of REGN is $8.14B
What is the all time high annual operating expenses for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total operating expenses is $8.14B
What is Regeneron Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, REGN annual total operating expenses has changed by +$1.07B (+15.16%)
What is Regeneron Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of REGN is $1.97B
What is the all time high quarterly operating expenses for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total operating expenses is $2.23B
What is Regeneron Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, REGN quarterly total operating expenses has changed by +$12.90M (+0.66%)